Skip to main content
HNGE logo

Hinge Health, Inc. (HNGE) Stock: Price, Forecast & Analyst Target

Hinge Health, Inc. (HNGE) — MoonshotScore 97/100 (Exceptional band), calculated Nov 18, 2026. Price $108.10 (-5.61%), as of the Nov 19, 2026 trading session; market cap $8.79B. Expected results Feb 9, 2027.

Educational signal · not a buy or sell recommendation · How to read this

Market value / cash and short-term investments: 29.83× (cash as of Sep 30, 2026) · expected results Feb 9, 2027

$108.10 −$6.43 (-5.61%) Market Cap $8.79B

Hinge Health, Inc. · HNGE · NYSE · Healthcare · Medical - Healthcare Information Services

Research dated 2026-09-13: Hinge Health sells specialized software for musculoskeletal care, spanning acute injuries, chronic pain and rehabilitation rather than operating as a general healthcare information vendor. The case depends on whether rising revenue, expanding operating profit and strong cash generation can persist while the company absorbs Cylinder without weakening its capital-light economics.

Price as of Nov 19, 2026

Key Statistics

97 of 100

MoonshotScore v2 · Hinge Health (HNGE)

Exceptional
Business Quality Elite (96)
Financial Safety Sound (70)
Valuation Rich (37)
Growth Durability Compounding (96)
Momentum Surging (99)
Why this rating? Method, drivers & history

Bands for the MoonshotScore: Exceptional 80-100 · Strong 65-79 · Fair 45-64 · Weak below 45.

  • Business Quality — Is this a genuinely good business?
  • Financial Safety — Could this blow up on me?
  • Valuation — Am I paying a fair price?
  • Growth Durability — Is the growth real and likely to last?
  • Momentum — Is the market already moving on this?
The ten-second read ·

Elite quality, a strong balance sheet and elite growth, but an expensive valuation; the market is already moving on it. Business Quality: Elite; Financial Safety: Sound; Valuation: Rich; Growth Durability: Compounding; Momentum: Surging.

  • quarterly revenue $154M (Q3 FY2025, quarter ended Sep 2025)
  • EPS beat 0 of the last 4 reports
  • Altman Z 9.79 · Piotroski F 6

Helping: business quality, balance-sheet strength, durable growth, positive momentum

What has the MoonshotScore done over time?

MoonshotScore snapshots recorded for HNGE (58 recorded, newest six shown)
RecordedScoreBand
95Exceptional
94Exceptional
94Exceptional
97Exceptional
97Exceptional
97Exceptional

Daily score refresh is delayed. This is the last recorded calculation.

Calculation uses the most recent completed US trading session. Live price changes do not update the score immediately.

Computed · How the MoonshotScore is computed →

Price & valuation

Dates shown where recorded
MeasureValueAs of
Latest provided price$108.10
Change on the day-5.61%
52-week range$30.08–$126.40
Market capitalisation$8.79B—
Price / earnings (trailing)55.00
Shares traded on the day1.69M
Beta (volatility vs the S&P 500)1.36

Price & events

Weekly closing price with reported quarters marked Weekly closing price from Oct 17, 2025 to Nov 19, 2026: low $31, high $116, latest $108. 4 reported quarters marked, 3 above and 1 below the recorded estimate. 1 other dated event marked. $116 $31 high $116 Feb 10, 2026 · Earnings results · reported above the recorded estimate · close $391May 5, 2026 · Earnings results · reported above the recorded estimate · close $562Aug 4, 2026 · Earnings results · reported below the recorded estimate · close $893Nov 2, 2026 · Earnings call · management outlook · no recorded estimate to compare · close $1144Nov 2, 2026 · Earnings results · reported above the recorded estimate · close $1145 Oct 17, 2025 Nov 19, 2026 · $108 $49Oct 17, 2025$50Oct 31, 2025$41Nov 14, 2025$49Nov 28, 2025$50Dec 12, 2025$48Dec 26, 2025$48Jan 9, 2026$43Jan 23, 2026$31Feb 6, 2026$41Feb 20, 2026$46Mar 6, 2026$42Mar 20, 2026$39Apr 2, 2026$43Apr 17, 2026$45May 1, 2026$55May 15, 2026$56May 29, 2026$65Jun 12, 2026$79Jun 26, 2026$89Jul 10, 2026$74Jul 24, 2026$89Aug 7, 2026$88Aug 21, 2026$92Sep 4, 2026$95Sep 18, 2026$98Oct 2, 2026$99Oct 16, 2026$114Oct 30, 2026$115Nov 13, 2026

Triangles mark reported quarters on the line: pointing up is above the recorded estimate, down is below, a diamond means no estimate on file or a dated event that is not a results report. Numbers key to the dated list. Point at or tab to any week for its close.

Events behind the price

  • · Earnings results · above the recorded estimate
  • · Earnings results · above the recorded estimate
  • · Earnings results · below the recorded estimate
  • · Earnings call · management outlook
  • · Earnings results · above the recorded estimate

Results dates follow the earnings feed; call dates follow the transcript provider. Nearby dates do not establish that an event caused a price move.

Upcoming events

As of

  1. Next results dueProvider estimate

Management outlook

  • We expect meaningful growth in revenue contribution to come in 2028, once we've had a full 2027 selling season with the integrated program. While I love where Migraine and GI are headed, I want to remind everyone that core MSK is still our largest revenue contributor by a wide margin, is growing robustly, and we expect it to remain that way for years to come.

    Daniel Perez · Statement from

How to read these dates

A statement's date is the earnings call where it was made, not a deadline. Management expectations and estimated dates can change.

What to watch next

Other perspectives

Council score for Hinge Health (HNGE): perspectives

Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.

5-Factor Breakdown

Business Quality Strong
Financial Safety Moderate
Valuation Weak
Growth Durability Strong
Momentum Strong

Legends Council

6 lenses, 6 current

AI simulations built from the named investors' published principles. Not affiliated with, endorsed by, or the opinion of these individuals. How these lenses are built

Dalio-style lens (simulated) Ray Dalio Favorable read
Griffin-style lens (simulated) Ken Griffin Neutral read
Simons-style lens (simulated) Jim Simons Neutral read
Englander-style lens (simulated) Izzy Englander Favorable read
Klarman-style lens (simulated) Seth Klarman Neutral read
Moon AI lens (model) Neutral read

Read on: Nov 21, 2026

Munger's Mindset

Balance Sheet & Valuation · historical

Financial Health Moderate
Margin of Safety Overvalued
Profit Margin Strong
Revenue Growth Strong
Debt/Equity Moderate
ROE Strong
Gross Margin Strong

Read on: Nov 19, 2026 · older than the 27 hours refresh window; not a current reading

How to read these bars and different assessments

Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.

Bars show each model's ordered assessment on its own scale, not a probability or a comparable investment return. The adjacent words give the assessment; more filled segments indicate a stronger model reading.

On Nov 19, 2026, the Munger lens read the price at that time as overvalued against its own estimate of value.

Readings on this page are from Nov 21, 2026, except a card that shows its own read date.

1 · What is it?

What is Hinge Health (HNGE), and what does it report?

Short answer · as of

Hinge Health provides a software platform that manages musculoskeletal and joint-health needs, with administrative and operational support around the care offering.

Demand therefore reflects use of a specialized care platform, not patient visits through a physical clinic network.

The accounts present the business as a consolidated reportable segment. Revenue, gross profit and operating expenses describe the platform as a whole, so the reported figures do not separate acute care, chronic pain, rehabilitation or administrative support into distinct business lines.

2 · Latest results

What do the latest results show for Hinge Health (HNGE)?

Short answer · as of

The most recent reported quarter, Q3 FY2025, carried revenue of $154M.

The latest results extended a sequence of rising revenue and gross profit. Operating profit, net income and operating cash flow also strengthened, while the latest reported revenue exceeded the prevailing estimate and earnings came in slightly below its estimate.

The mechanism visible in the accounts is gross-profit expansion alongside controlled operating spending. Research and development and administrative costs increased, but the additional gross profit was sufficient to produce higher operating income. Management presented Cylinder as a future contribution rather than the explanation for the reported period.

Where is operating spending going?

Revenue alongside research and development, selling, general and administrative expenses, and the FMP standardized operating result.

Latest quarter · revenue
$234.97M Sep 30, 2026
Latest quarter · R&D
$37.47M Sep 30, 2026
Latest quarter · SG&A
$116.53M Sep 30, 2026
Latest quarter · FMP standardized operating result
$50.33M Sep 30, 2026
Period endRevenueR&DSG&AFMP standardized operating result
Sep 30, 2026$234.97M$37.47M$116.53M$50.33M
Jun 30, 2026$212.82M$34.06M$109.45M$40.44M
Mar 31, 2026$182.31M$30.34M$91.83M$32.07M
Dec 31, 2025$170.73M$32.76M$83.50M$27.26M
How to read these figures

Amounts are in US dollars. The operating result is Financial Modeling Prep’s standardized figure, so it can differ from the operating line in the company’s filing. It is not net income or cash flow.

Did results meet expectations?

Reported earnings and revenue alongside the estimates recorded by the provider.

Latest report · revenue
$234.97M Nov 2, 2026
Latest report · revenue estimate
$224.78M Nov 2, 2026
Latest report · revenue vs estimate
Above estimate Nov 2, 2026
Latest report · EPS vs estimate
Above estimate Nov 2, 2026
Report dateRevenue · reportedRevenue · estimateEPS · reportedEPS · estimate
Nov 2, 2026$234.97M$224.78M$0.7100$0.5760
Aug 4, 2026$212.82M$201.46M$0.5900$0.6150
May 5, 2026$182.31M$172.20M$0.4500$0.3900
Feb 10, 2026$170.73M$156.66M$0.4900$0.0400
How to read these figures

Dates are when results were reported, not quarter ends. Amounts are in US dollars; EPS is per share. The source does not say whether EPS is basic, diluted or adjusted, so it can differ from the EPS in the income statement.

Quarterly income statement — 4 quarters
Revenue, net income and earnings per share by quarter
PeriodRevenueNet incomeEPS
Q3 FY2025$154M-$2M-$0.02 (diluted)
Q4 FY2025$171M$32M$0.37 (diluted)
Q1 FY2026$182M$35M$0.41 (diluted)
Q2 FY2026$213M$44M$0.53 (diluted)
3 · Financial strengths and risks

What are the financial strengths and risks for Hinge Health (HNGE)?

Short answer

Cash and short-term investments were $294.65M at the Sep 30, 2026 balance-sheet date. Operating cash flow was $114.60M for the quarter ended Sep 30, 2026, meaning operations generated cash. These figures do not establish a cash runway.

Liquidity is a genuine strength: cash and investments substantially exceed debt, operating cash flow has remained positive across the reported sequence, and capital expenditure has been modest. The balance sheet therefore provides room to fund operations and strategic investment without relying heavily on borrowing.

Cylinder changes that cushion because management expects a material cash outlay and must still integrate and scale the acquired offering. The other pressure point is valuation: the market value stands far above net cash and trailing sales, so weaker growth or erosion in the platform's high gross margin could challenge the assumptions embedded in the shares.

Data-derived red flags

  • Inconsistent delivery — missed Wall Street EPS estimates in 0 of the last 4 reported quarters.
  • Rich valuation — a P/E of 55.00 runs well above the Healthcare sector’s ~21.70x, leaving little room for a miss.

How much cash does the business generate or use?

Quarterly operating cash flow shows cash generated or used by operations.

Latest quarter · operating cash flow
$114.60M Sep 30, 2026
Previous quarter · operating cash flow
$101.41M Jun 30, 2026
Period endOperating cash flowCapital expenditure (reported)
Sep 30, 2026$114.60M−$1.94M
Jun 30, 2026$101.41M−$1.85M
Mar 31, 2026$43.08M−$80,000
Dec 31, 2025$63.90M−$410,000
How to read these figures

Amounts are in US dollars. Negative operating cash flow means the business used cash. Capital spending is shown as reported; we do not combine it into a free-cash-flow or runway estimate. The bars share one scale.

4 · What to check next?

What should you watch next at Hinge Health (HNGE)?

Short answer · as of

The next earnings report is expected on Feb 9, 2027.

Watch whether reported revenue continues to rise while gross margin, operating profit and operating cash flow hold their recent direction. Revenue growth without comparable cash conversion would weaken the evidence that the platform is scaling efficiently.

Cylinder deserves separate attention: closing cash, the initial revenue contribution and management's progress integrating the offering will show whether the acquisition broadens growth without consuming too much liquidity. The next earnings release also provides a direct check against expectations that currently assume continued revenue and earnings expansion.

What management is planning

Management's statement is quoted under Upcoming events

What the records here don't tell us

  • The newest quarter held here (Q3 FY2025) was filed Nov 7, 2025 — 12 months ago.

Checked against the records this page reads, on the dates shown above.

5 · Peer comparison

How does Hinge Health compare with its peers?

Short answer

Hinge Health's score ranks tied for 1st of 13 in the bounded comparison shown, against 12 same-model peers. These are company scores, not expected investment returns. The set lists named competitors first, then companies in the same data-provider industry classification closest in market value; that classification is the provider's, not our judgment of business similarity.

Hinge Health's economics resemble specialized software more than a clinic network: gross margins are high, capital spending is light, and the product coordinates musculoskeletal care through a platform. Yet it is narrower than broad healthcare administration software because the offering is built around joint health, injuries, chronic pain and rehabilitation.

That combination concentrates the story. Investors do not receive separate segment disclosures for different care needs, so platform growth, gross-profit conversion and cash generation must carry the comparison with other digital-health businesses.

Peer set — price, market value and MoonshotScore
CompanyPriceMarket valueScore
Hinge Health (HNGE) — this page$108.10$8.79B97
Oscar Health, Inc. (OSCR) Named competitor$26.17 Nov 19, 2026$8.13B97 5-pillar Nov 18, 2026
Lantheus Holdings, Inc. (LNTH) Named competitor$102.10 Nov 19, 2026$6.68B96 5-pillar Nov 18, 2026
Doximity, Inc. (DOCS) Same industry, near in market value$29.61 Nov 19, 2026$5.28B95 5-pillar Nov 18, 2026
Progyny, Inc. (PGNY) Same industry, near in market value$35.45 Nov 19, 2026$2.61B95 5-pillar Nov 18, 2026
HealthEquity, Inc. (HQY) Same industry, near in market value$97.38 Nov 19, 2026$8.05B90 5-pillar Nov 18, 2026
BrightSpring Health Services, Inc. (BTSG) Same industry, near in market value$64.02 Nov 19, 2026$12.7B87 5-pillar Nov 18, 2026
Privia Health Group, Inc. (PRVA) Same industry, near in market value$24.69 Nov 19, 2026$3.15B79 5-pillar Nov 18, 2026
GE HealthCare Technologies Inc. (GEHC) Same industry, near in market value$81.89 Nov 19, 2026$37.0B74 5-pillar Nov 18, 2026
Praxis Precision Medicines, Inc. (PRAX) Named competitor$310.90 Nov 19, 2026$8.69B60 5-pillar Nov 18, 2026
10x Genomics, Inc. (TXG) Same industry, near in market value$57.38 Nov 19, 2026$7.55B38 5-pillar Nov 18, 2026
HeartFlow, Inc. (HTFL) Same industry, near in market value$44.63 Nov 19, 2026$3.92B35 5-pillar Nov 18, 2026
Tempus AI, Inc. (TEM) Same industry, near in market value$59.61 Nov 19, 2026$10.9B33 5-pillar Nov 18, 2026

Only 5-pillar scores are ranked together. Other models are not directly comparable. Price and score dates are shown separately; market-value dates are unavailable.

Screen more Healthcare stocks

The records behind this page

Analyst targets & estimates

What analysts have on file

Price target, low to high
$80.00 – $140.00
Consensus target
$116.62
Median target
$112.00

Consensus record · Captured .

Measured against a quoted price of $108.10 (as of Nov 19, 2026).

Insider activity

Form 4 records via FMP · Of the newest 500 records, those within the last 180 days, newest dated Nov 11, 2026

Transactions
226
Identified insiders
8
Purchases
0
Sales
116
Other transactions
110

Purchases and sales use the reported transaction category. Other transactions include awards, exercises, gifts, withholding and unclassified activity; an acquisition or disposition alone is not a purchase or sale. These records do not establish intent.

Who holds the shares?

Institutional ownership reported through 13F filings.

Institutional ownership
84.5% Period end Sep 30, 2026
Previous quarter · ownership
73.4% Prior to period end Sep 30, 2026
Reporting holders
383 Period end Sep 30, 2026
Previous quarter · holders
292 Prior to period end Sep 30, 2026
Holders in provider snapshotShares
Blackrock, INC.4,411,378
Two Sigma Investments, LP2,559,509
Vanguard Capital Management LLC2,513,093
Vanguard Portfolio Management LLC2,492,160
Morgan Stanley2,453,365

Tracked investors

Which of the 16 named investors we follow held HNGE in their latest 13F filing, and what they did against the filing before it.

None of the 16 tracked investors reported HNGE in their latest 13F filing.

See all tracked investor portfolios

How to read these figures

These filings arrive after the quarter ends. Names appear as the provider lists them, not as a verified ranking, and without filing dates. Related managers can appear separately, so their shares are not added together. Holder snapshot as of Sep 30, 2026. Tracked investors: each fund's own latest 13F, so funds that have not filed the newest quarter yet show their previous one; weight is the share of the fund's reported 13F value.

What has been published about Hinge Health (HNGE)?

Read these with our analysis →

HNGE Healthcare Stock FAQ

The last 2 questions are answered from this page's own dated data, not from the research.

What does the Hinge Health platform manage?

The platform covers musculoskeletal and joint health across acute injuries, persistent pain and post-operative rehabilitation, supported by administrative and operational services. Those activities are reported together rather than as separately disclosed segments.

Why does Cylinder matter to Hinge Health?

Cylinder is expected to add revenue after closing and to become more meaningful as Hinge Health integrates and scales the offering. It also requires a material cash payment, making post-close liquidity and execution important checks on the transaction.

Is Hinge Health producing cash as earnings improve?

Operating cash flow has been positive throughout the reported sequence and strengthened alongside recent profitability. Low capital spending means most of that operating cash generation has not been absorbed by physical investment, although the cash balance has moved unevenly over time.

What is creating Hinge Health's recent operating leverage?

Gross profit has risen faster than the operating expense base, allowing operating income to expand even as research, development and administrative spending increased. High gross margins and modest capital requirements reinforce the platform's software-like financial profile.

What is the HNGE stock price today?

The last price recorded for Hinge Health, Inc. (HNGE), with its trading session and source, is listed under Price & valuation on this page. It is a provider snapshot, not a live exchange feed, so check a brokerage quote before you trade.

What is the HNGE price target?

The analyst consensus price target for Hinge Health, Inc. (HNGE), with its range and the date it was captured from FMP, is listed under Analyst targets & estimates on this page. Targets are analyst opinions and change often; they are not a Stock Expert AI forecast.

Research written by Codex (gpt-5.6-sol) on 2026-09-13. AI-authored analysis; source dates are listed under Sources. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief.

Sources: the source register lists the 83 figures on this page — 2 from SEC filings and earnings calls, 75 from Financial Modeling Prep (FMP), 2 with no recorded source, 3 computed by us, formula shown in the register and 1 from Stock Expert AI's own score and rank. Its rows (value as shown, as-of date, tier and source link) are in the Markdown version of this page.

Publication details and research sources
Published
Research standards
Methodology · Editorial policy · Corrections

Sources (as of 2026-09-13), by section of the research

  • Summary at the top of the page: Business description; Quarterly income statement (USD thousands); Operating cash flow by quarter (USD millions); Management outlook — dated call excerpts
  • 1. What is Hinge Health (HNGE), and what does it report?: Business description; Revenue by segment; Quarterly income statement (USD thousands); Annual revenue and net result (USD millions)
  • 2. What do the latest results show for Hinge Health (HNGE)?: Quarterly income statement (USD thousands); Operating cash flow by quarter (USD millions); Reported versus estimated, last 7 quarters; Trailing twelve-month ratio set; Management outlook — dated call excerpts
  • 3. What are the financial strengths and risks for Hinge Health (HNGE)?: Cash, investments and debt; Cash and investment components; Operating cash flow by quarter (USD millions); Cash and short-term investments over time (USD millions); Cash against market value; Trailing twelve-month ratio set; Management outlook — dated call excerpts
  • 4. What should you watch next at Hinge Health (HNGE)?: Quarterly income statement (USD thousands); Operating cash flow by quarter (USD millions); Cash, investments and debt; Management outlook — dated call excerpts; Next earnings report; Analyst revenue and earnings estimates (average); Recent SEC filings
  • 5. How does Hinge Health compare with its peers?: Business description; Revenue by segment; Trailing twelve-month ratio set; Operating cash flow by quarter (USD millions); Quarterly income statement (USD thousands)
  • FAQ: What does the Hinge Health platform manage?: Business description; Revenue by segment; Annual revenue and net result (USD millions)
  • FAQ: Why does Cylinder matter to Hinge Health?: Management outlook — dated call excerpts; Cash, investments and debt; Cash and investment components; Recent SEC filings
  • FAQ: Is Hinge Health producing cash as earnings improve?: Operating cash flow by quarter (USD millions); Quarterly income statement (USD thousands); Cash and short-term investments over time (USD millions); Trailing twelve-month ratio set
  • FAQ: What is creating Hinge Health's recent operating leverage?: Quarterly income statement (USD thousands); Trailing twelve-month ratio set; Operating cash flow by quarter (USD millions)
Data Sources & Methodology
Figures come from Financial Modeling Prep (FMP). If FMP has no figure for a ticker, a price or fundamental may come from a Yahoo Finance fallback, or a price from an Alpaca fallback. SEC EDGAR is used only for filing links and company identity details (legal name, address), never for figures. AI analysis by Stock Expert AI proprietary algorithms. Technical indicators via industry-standard calculations. Last updated: .
Data Provenance
Sources: Financial Modeling Prep (FMP) — Primary · Yahoo Finance — Fallback · Alpaca — Tertiary
Last fetched:
Cache TTL: Quote 5min · Profile 7d · Financials 7d · Insider 48h
How we use AI: Numbers are pulled directly from FMP & Yahoo Finance — our AI writes the analysis, it never edits the figures.